MedTrace Logo

Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis

NCT07556393 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2026-04-29

No results posted yet for this study

Summary

The purpose of this trial is to see how well an experimental nasal spray, called INI-2004, works for those with allergy symptoms to ragweed. This nasal spray will compare how well 500mcg of INI-2004, given once per week for 4 weeks, works at reducing ragweed allergy symptoms in an Environmental Exposure Unit (EEU), compared to placebo.

Conditions

Interventions

DRUG

INI-2004

Toll-like receptor \[TLR\]4 agonist liposomal formulation

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Rho, Inc.

    collaborator INDUSTRY

  • Inimmune Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-19
Primary Completion
2026-04-23
Completion
2026-04-23

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07556393 on ClinicalTrials.gov